CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$2.59B
(+22%)
Cap. Flow
+$828M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
364
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
426
DELISTED
CATALENT, INC.
CTLT
| $4.39M | 0.03% |
40,616
+30,046
| +284% | +$3.25M |
|
|
FLY
427
DELISTED
Fly Leasing Limited
FLY
| $4.39M | 0.03% |
+259,121
| New | +$4.39M |
|
428
Outset Medical
OM
$249M
| $4.38M | 0.03% |
5,837
+2,414
| +71% | +$1.81M |
|
|
429
Allstate
ALL
$52.9B
| $4.37M | 0.03% |
33,516
-404,347
| -92% | -$52.7M |
|
430
Generac Holdings
GNRC
$10.5B
| $4.37M | 0.03% |
10,517
-99,008
| -90% | -$41.1M |
|
431
Yum China
YUMC
$16.4B
| $4.35M | 0.03% |
65,600
+5,218
| +9% | +$346K |
|
432
Assembly Biosciences
ASMB
$193M
| $4.32M | 0.03% |
92,813
-1,899
| -2% | -$88.4K |
|
433
Keros Therapeutics
KROS
$630M
| $4.31M | 0.03% |
+101,409
| New | +$4.31M |
|
434
Snowflake
SNOW
$75.8B
| $4.27M | 0.03% |
+17,637
| New | +$4.27M |
|
|
ISEE
435
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.26M | 0.03% |
+675,575
| New | +$4.26M |
|
436
Old Dominion Freight Line
ODFL
$31.4B
| $4.24M | 0.03% |
33,388
-35,010
| -51% | -$4.44M |
|
437
iShares MSCI Canada ETF
EWC
$3.25B
| $4.22M | 0.03% |
113,314
-2,277
| -2% | -$84.9K |
|
438
OrthoPediatrics
KIDS
$522M
| $4.19M | 0.03% |
+66,369
| New | +$4.19M |
|
439
Baxter International
BAX
$12.4B
| $4.16M | 0.03% |
51,699
-69,647
| -57% | -$5.61M |
|
440
Zoom
ZM
$25.1B
| $4.15M | 0.03% |
10,731
+1,403
| +15% | +$543K |
|
441
Kulicke & Soffa
KLIC
$2.01B
| $4.13M | 0.03% |
+67,421
| New | +$4.13M |
|
442
Roper Technologies
ROP
$55.8B
| $4.09M | 0.03% |
8,701
-8,357
| -49% | -$3.93M |
|
|
PVLA
443
Palvella Therapeutics, Inc. Common Stock
PVLA
$626M
| $4.07M | 0.03% |
13,273
-15,136
| -53% | -$4.64M |
|
|
BLDP
444
Ballard Power Systems
BLDP
$601M
| $4.06M | 0.03% |
224,096
+42,155
| +23% | +$764K |
|
445
CDW
CDW
$22.2B
| $3.97M | 0.03% |
22,706
-13,240
| -37% | -$2.31M |
|
446
Avidity Biosciences
RNA
$6.32B
| $3.95M | 0.03% |
159,988
+140,491
| +721% | +$3.47M |
|
447
Martin Marietta Materials
MLM
$37.5B
| $3.95M | 0.03% |
11,213
-718
| -6% | -$253K |
|
448
Viatris
VTRS
$12.1B
| $3.94M | 0.03% |
275,840
+19,290
| +8% | +$276K |
|
449
Chevron
CVX
$312B
| $3.94M | 0.03% |
37,628
+5,175
| +16% | +$542K |
|
450
Honeywell
HON
$136B
| $3.94M | 0.03% |
17,963
-464
| -3% | -$102K |
|